Cytomegalovirus Reactivation Promotes CD8+T Cell Subset Recovery after Unmodified Allogeneic Hematopoietic Cell Transplantation

被引:0
|
作者
Jain, Tania [1 ]
Cho, Christina [2 ]
Hilden, Patrick [3 ]
Politikos, Ioannis [2 ]
Borrill, Taylor [2 ]
Giralt, Sergio A. [4 ]
Maslak, Peter [5 ]
O'Reilly, Richard J. [6 ]
van den Brink, Marcel R. M. [4 ]
Perales, Miguel-Angel [4 ]
机构
[1] Mem Sloan Kettering, Div Hematol, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, Adult Bone Marrow Transplant Serv, Dept Med, 1275 York Ave, New York, NY 10021 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Biostat & Epidemiol, 1275 York Ave, New York, NY 10021 USA
[4] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[5] Mem Sloan Kettering Canc Ctr, Dept Lab Med, 1275 York Ave, New York, NY 10021 USA
[6] Mem Sloan Kettering Canc Ctr, Dept Pediat, Bone Marrow Transplant Serv, 1275 York Ave, New York, NY 10021 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
483
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Allogeneic Hematopoietic Cell Transplantation Promotes Atherosclerosis in Mice Driven By Donor CD8+T Cells
    Shaikh, Haroon
    Jorgaecevic, Ivana
    Ali, Hla
    Bundalo, Maja
    Schafer, Sarah
    Kern, Michael A. G.
    Buettner-Herold, Maike
    Cochain, Clement
    Saliba, Antoine-Emmanuel
    Rizzo, Giuseppe
    Vargas, Juan
    Boon, Louis
    Herr, Wolfgang
    Einsele, Hermann
    Berberich-Siebelt, Friederike
    Rosenwald, Andreas
    Beilhack, Andreas
    Zernecke, Alma
    BLOOD, 2024, 144 : 3402 - 3403
  • [2] Vancomycin use and cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation
    Zhang, Shijia
    Shanley, Ryan
    Weisdorf, Daniel J.
    Rashidi, Armin
    BLOOD ADVANCES, 2020, 4 (12) : 2640 - 2643
  • [3] Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation
    Almyroudis, N. G.
    Jakubowski, A.
    Jaffe, D.
    Sepkowitz, K.
    Pamer, E.
    O'Reilly, R. J.
    Papanicolaou, G. A.
    TRANSPLANT INFECTIOUS DISEASE, 2007, 9 (04) : 286 - 294
  • [4] Cytomegalovirus reactivation. Risk factors after allogeneic hematopoietic cell transplantatioN
    Otermin, Florencia
    Ruben Cremona, Alberto
    Ramirez Borga, Santiago Jose
    Pessacq, Pedro
    Milagros Szelagowski, Maria
    Miguel De Luca, Teofilo
    Farina, Javier
    BONE MARROW TRANSPLANTATION, 2019, 54 : 448 - 449
  • [5] Cytomegalovirus reactivation. Risk factors after allogeneic hematopoietic cell transplantation
    Otermin, F.
    Cremona, A.
    Pessacq, P.
    Ramirez Borga, S. J.
    De Luca, T.
    Szelagowski, M. M.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2018, 73 : 5 - 5
  • [6] The association of conditioning regimen with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation
    Mardani, Masoud
    Abolghasemi, Sara
    Shabani, Shiva
    Tavakoli, Farzaneh
    Saeedi, Anahita
    Parkhideh, Sayeh
    Hajifathali, Abbas
    IRANIAN JOURNAL OF MICROBIOLOGY, 2020, 12 (06) : 636 - 643
  • [7] Dasatinib Use and Risk of Cytomegalovirus Reactivation After Allogeneic Hematopoietic-Cell Transplantation
    Prestes, Daniel P.
    Arbona, Esther
    Nevett-Fernandez, Alexandra
    Woolley, Ann E.
    Ho, Vincent T.
    Koo, Sophia
    Baden, Lindsey R.
    Koreth, John
    Hammond, Sarah P.
    Issa, Nicolas C.
    Marty, Francisco M.
    CLINICAL INFECTIOUS DISEASES, 2017, 65 (03) : 510 - 513
  • [8] Invariant natural killer t cells protect from cytomegalovirus reactivation after allogeneic hematopoietic cell transplantation
    Schneidawind, D.
    Duerr-Stoerzer, S.
    Keppeler, H.
    Beck, R.
    Hamprecht, K.
    Kanz, L.
    Schneidawind, C.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 159 - 159
  • [9] REGULATORY T CELL RECOVERY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Ngoma, A.
    Ikeda, K.
    Ohto, H.
    Saitou, S.
    Yasuda, H.
    Ogawa, K.
    Mochizuki, K.
    Sasaki, K.
    VOX SANGUINIS, 2009, 97 : 175 - 175
  • [10] Polyomavirus-specific CD8+T cell responses in patients after allogeneic stem cell transplantation
    Schneidawind, D.
    Mani, J.
    Schmitt, A.
    Bunjes, D.
    Freund, M.
    Schmitt, M.
    ONKOLOGIE, 2010, 33 : 28 - 29